Search research articles
Contact Us
Filters
Showing results (591-600 of 635) with videos related to
Page
of 64
Sort By:
Nature Genetics
|
February 3, 2009
Variant in the sequence of the LINGO1 gene confers risk of essential tremor
Hreinn Stefansson, Stacy Steinberg, Hjorvar Petursson, et al.
Scientific Reports
|
September 30, 2022
A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia
Louise Thorlacius-Ussing, Patrick Terrence Brooks, Henrik Nielsen, et al.
Diagnostic Microbiology and Infectious Disease
|
August 23, 2021
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories
Derek R Stein, Carla Osiowy, Ainsley Gretchen, et al.
Nature Genetics
|
November 18, 2025
African-ancestry-specific variant IKKβ p.Glu502Lys confers high lupus risk
Gudny Ella Thorlacius, Erna V Ivarsdottir, Saedis Saevarsdottir, et al.
Clinical Biochemistry
|
May 23, 2025
Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient care
Daniel R Beriault, Yu Chen, Paul Yip, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2024
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients
Amanda Frydendahl, Jesper Nors, Mads H Rasmussen, et al.
Journal of Medical Genetics
|
July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
A C Antoniou, P D P Pharoah, S Narod, et al.
American Journal of Human Genetics
|
April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
A Antoniou, P D P Pharoah, S Narod, et al.
British Journal of Cancer
|
October 10, 2024
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
Nadia Øgaard, Sarah Østrup Jensen, Mai-Britt Worm Ørntoft, et al.
Annals of Surgery
|
December 18, 2024
Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial
Ismail Gögenur, Tobias Freyberg Justesen, Line Schmidt Tarpgaard, et al.
Page
of 64
Search research articles
Search
Showing results (591-600 of 635) with videos related to
Sort By:
Page
of 64
Nature Genetics
|
February 3, 2009
Variant in the sequence of the LINGO1 gene confers risk of essential tremor
Hreinn Stefansson, Stacy Steinberg, Hjorvar Petursson, et al.
Scientific Reports
|
September 30, 2022
A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia
Louise Thorlacius-Ussing, Patrick Terrence Brooks, Henrik Nielsen, et al.
Diagnostic Microbiology and Infectious Disease
|
August 23, 2021
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories
Derek R Stein, Carla Osiowy, Ainsley Gretchen, et al.
Nature Genetics
|
November 18, 2025
African-ancestry-specific variant IKKβ p.Glu502Lys confers high lupus risk
Gudny Ella Thorlacius, Erna V Ivarsdottir, Saedis Saevarsdottir, et al.
Clinical Biochemistry
|
May 23, 2025
Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient care
Daniel R Beriault, Yu Chen, Paul Yip, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2024
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients
Amanda Frydendahl, Jesper Nors, Mads H Rasmussen, et al.
Journal of Medical Genetics
|
July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
A C Antoniou, P D P Pharoah, S Narod, et al.
American Journal of Human Genetics
|
April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
A Antoniou, P D P Pharoah, S Narod, et al.
British Journal of Cancer
|
October 10, 2024
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
Nadia Øgaard, Sarah Østrup Jensen, Mai-Britt Worm Ørntoft, et al.
Annals of Surgery
|
December 18, 2024
Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial
Ismail Gögenur, Tobias Freyberg Justesen, Line Schmidt Tarpgaard, et al.
Page
of 64